COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,629 Articles (22,913 medRxiv, 8,716 bioRxiv)

Most recent first Previous |  Page 1859: Articles 18581-18590  | Next

Modeling the Effect of Population-Wide Vaccination on the Evolution of COVID-19 Epidemic in Canada
Harizi, I., Berkane, S., Tayebi, A.
10.1101/2021.02.05.21250572 — Posted: 2021-02-08
INCLUSIVE HEALTH: MODELING COVID-19 IN CORRECTIONAL FACILITIES AND COMMUNITIES
Greenhalgh, S., Provencher, A.
10.1101/2021.02.05.21251174 — Posted: 2021-02-08
Design and Estimation for the Population Prevalence of Infectious Diseases
Oh, E. J., Mikytuck, A., Lancaster, V., Goldstein, J., Keller, S.
10.1101/2021.02.05.21251231 — Posted: 2021-02-08
How effective was Newfoundland & Labrador's travel ban to prevent the spread of COVID-19? An agent-based analysis
Aleman, D. M., Tham, B. Z., Wagner, S. J., Semelhago, J., Mohammadi, A., Price, P., Giffen, R., Rahman, P.
10.1101/2021.02.05.21251157 — Posted: 2021-02-08
UK and other SARS-CoV-2-Covariants - Simulation Modeling 70% Increase
Chang, E., Moselle, K. A.
10.1101/2021.02.05.21251230 — Posted: 2021-02-08
Outdoor transmission of COVID-19: Analysis of windspeed
Clouston, S., Morozova, O., Meliker, J.
10.1101/2021.02.05.21251179 — Posted: 2021-02-08 Discussion: Onsite
Modelling the impact of contact tracing of symptomatic individuals on the COVID-19 epidemic
Amaku, M., Covas, D. T., Coutinho, F. A. B., Azevedo, R. S., Massad, E.
10.1101/2021.02.05.21251222 — Posted: 2021-02-08
The antibody response to SARS-CoV-2 increases over 5 months in patients with anosmia/dysgeusia
Levi, R., Ubaldi, L., Pozzi, C., Angelotti, G., Sandri, M. T., Azzolini, E., Salvatici, M., Savevski, V., Mantovani, A., Rescigno, M.
10.1101/2021.02.05.21251219 — Posted: 2021-02-08
The kinetic variations of anti-nucleocapsid antibody in SARS-CoV-2 infection
Kawada, S., Ogata, A., Kato, Y., Okamoto, M., Yamaguchi, Y., Morita, T., Kumanogoh, A.
10.1101/2021.02.05.21251208 — Posted: 2021-02-08
Longitudinal Metabolomics of Human Plasma Reveals Robust Prognostic Markers of COVID-19 Disease Severity
Sindelar, M., Stancliffe, E., Schwaiger-Haber, M., Anbukumar, D. S., Albrecht, R. A., Liu, w.-c., Adkins-Travis, K., Garcia-Sastre, A., Shriver, L. P., Patti, G. J.
10.1101/2021.02.05.21251173 — Posted: 2021-02-08

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).